Potassium channel blockers as antiarrhythmic drugs

This publication has 44 references indexed in Scilit:

• Torsades de pointes with Almokalant, a new class III antiarrhythmic drug
  American Heart Journal, 1993
• Current status of class III antiarrhythmic drug therapy
  The American Journal of Cardiology, 1993
• Clinical evaluation of the use-dependent QRS prolongation and the reverse use-dependent QT prolongation of class I and class III antiarrhythmic agents and their value in predicting efficacy
  American Heart Journal, 1993
• Effects of WAY-123,398, a New Class III Antiarrhythmic Agent, on Cardiac Refractoriness and Ventricular Fibrillation Threshold in Anesthetized Dogs: A Comparison with UK-68798, E-4031, and dl-Sotalol
  Journal of Cardiovascular Pharmacology, 1992
• Electropharmacologic effects and pharmacokinetics of almokalant, a new class III antiarrhythmic, in patients with healed or healing myocardial infarcts and complex ventricular arrhythmias
  The American Journal of Cardiology, 1992
• Clinical and electrophysiologic effects of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with angina pectoris
  The American Journal of Cardiology, 1992
• Rate-Dependent Class III Antiarrhythmic Action, Negative Chronotropy, and Positive Inotropy of a Novel Ik Blocking Drug, UK-68,798
  Journal of Cardiovascular Pharmacology, 1990
• Clinical implications of new studies in the treatment of benign, potentially malignant and malignant ventricular arrhythmias
  The American Journal of Cardiology, 1990
• Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial Infarction
  New England Journal of Medicine, 1989
• A Classification of Antiarrhythmic Actions Reassessed After a Decade of New Drugs
  The Journal of Clinical Pharmacology, 1984